Geri Dön

5-sübstitüe/nonsübstitüe 1H-indol-2-on-3-iliden türevlerinin sentezi ve yapılarının aydınlatılması

Synthesis and evaluation of structures of 5-substituted/nonsubstituted 1H-indole-2-one-3-ylidene derivatives

  1. Tez No: 158177
  2. Yazar: HANDAN ALTINTAŞ
  3. Danışmanlar: PROF.DR. ÖZNUR ATEŞ
  4. Tez Türü: Doktora
  5. Konular: Eczacılık ve Farmakoloji, Pharmacy and Pharmacology
  6. Anahtar Kelimeler: Belirtilmemiş.
  7. Yıl: 2004
  8. Dil: Türkçe
  9. Üniversite: İstanbul Üniversitesi
  10. Enstitü: Sağlık Bilimleri Enstitüsü
  11. Ana Bilim Dalı: Farmasötik Kimya Ana Bilim Dalı
  12. Bilim Dalı: Belirtilmemiş.
  13. Sayfa Sayısı: 256

Özet

Facility (TAACF) Southern Research Institute'de antitüberküler, Fakültemiz Farmakoloji Anabilim Dalı'nda antikonvülsan aktiviteleri araştırılmıştır. Tüm maddelerimiz antifungal aktivite gösterirken, madde I-XII S.epidermidis'e, madde IV, VI, X-XII S.aureus'a karşı antibakteryel aktivite göstermiştir. Maddelerimizin antitüberküler etki araştırmasında, I-XX numaralı maddelerimiz Mycobacterium tuberculosis H37Rv suşuna karşı 6.25 ng/ml konsantrasyonda test edilmiş, ancak en fazla %12 inhibisyon gösterdiği saptanmıştır. Antikonvülsan etki araştırmasında ise prototip olarak seçilen I, IV, V, VI, VIII, XI, XIII, XVI, XVII ve XVIII numaralı maddelerimizden madde I ve VI hariç diğerlerinin nöbet latensinde istatistiksel olarak anlamlı bir artış gösterdiği ve PTZ nin nöbet eşiğini yükseltiği görülmüştür. Bu nedenle maddelerin antikonvülsan aktivite açısından umut verici bileşikler olabileceği ve daha ileri testlerde yüksek dozlarda çalışılmasına devam edilmesinin uygun olacağı düşünülmektedir. 225SUMMARY In this work, 20 novel compounds, 5-substituted/nonsubstituted 1H- indole-2-one-3-ylidene derivatives have been synthesized. 3-[2-[5-(p-methoxyphenyl)-1,3,4-oxadiazol-2-yl]imino-4-thiazolidinon-5- ylidene]-1 H-indole-2-one (I) 3-[2-[5-(p-methoxyphenyl)-1,3,4-oxadiazol-2-yl]imino-4-thiazolidinon-5- ylidene]-1-methyl-indole-2-one (II) 3-[2-[5-(p-methoxyphenyl)-1,3,4-oxadiazol-2-yl]imino-4-thiazolidinon-5- ylidene]-5-methyl-1 H-indole-2-one (III) 3-[2-[5-(p-methoxyphenyl)-1,3,4-oxadiazol-2-yI]imino-4-thiazolidinon-5- ylidene]-5-nitro-1 H-indole-2-one (IV) 3-[2-[5-(p-methoxyphenyl)-1,3,4-oxadiazol-2-yl]imino-4-thiazolidinon-5- ylidene]-5~bromo~1 H-indole-2-one (V) 3-[2-[5-(p-methoxyphenyl)-1,3,4-oxadiazol-2-yl]imino-4-thiazoIidinon-5- ylidene]-5-fluoro-1 H-indole-2-one (VI) 3-[2-[5-(p-methoxyphenyl)-1,3,4-oxadiazol-2-yl]imino-4-thiazolidinon-5- ylidene]-5-trifIuoromethoxy-1 H-indole-2-one (VII) 3-[2-[5-(p-chlorophenyl)-1,3,4-oxadiazol-2-yl]imino-4-thiazoIidinon-5- ylidene]-1 H-indole-2-one (VIII) 3-[2-[5-(p-chlorophenyl)-1,3,4-oxadiazol-2-yl]imino-4-thiazolidinon-5- ylidene]-1 -methyl-indoIe-2-one (IX) 3-[2-[5-(p-chlorophenyl)-1,3,4-oxadiazol-2-yl]imino-4-thiazolidinon-5- ylidene]-5-nitro-1 H-indole-2-one (X) 3-[2-[5-(p-chlorophenyl)-1,3,4-oxadiazol-2-yl]imino-4-thiazolidinon-5- ylidene]-5-bromo-1 H-indole-2-one (XI) 3-[2-[5-(p-chlorophenyl)-1,3,4-oxadiazol-2-yl]imino-4-thiazolidinon-5- ylidene]-5-fluoro-1 H-indole-2-one (XII) 3-[2-(4-carbethoxymethylthiazol-2-yl)imino-4-thiazolidinon-5-ylidene]- 1H-indole-2-one(XIII) 2263-[2-(4-carbethoxymethyIthiazol-2-yI)imino-4-thiazolidinon-5-ylidene]-1- methyI-indole-2-one (XIV) 3-[2-(4-carbethoxymethylthiazol-2-yl)imino-4-thiazolidinon-5-ylidene]-5- methyI-1H-indole-2-one (XV) 3-[2-(4-carbethoxymethylthiazol-2-yl)imino-4~thiazoIidinon-5-ylidene]-5~ nitro1H-indole-2-one (XVI) 3-[2-(4-carbethoxymethylthiazol-2-yl)imino-4-thiazolidinon-5-yIidene]-5- bromo-1H-indole-2-one (XVII) 3-[2-(4-carbethoxymethylthiazol-2-yl)imino-4-thiazolidinon-5-ylidene]-5- fluoro-1H-indole-2-one (XVIII) 3-[2-(4-carbethoxymethylthiazol-2-yl)imino-4-thiazolidinon-5-ylidene]-5- trifluoromethoxy-1 H-indole-2-one (XIX) 3-[2-(4-carbethoxymethylthiazol-2-yl)imino-4-thiazolidinon-5-ylidene]-5- sulfonic acid sodium salt -1 H-indole-2-one (XX) With this purpose, 2-amino-5-(p-methoxy/p-chlorophenyl)-1,3,4- oxadiazole or 2-amino-4-carbethoxymethylthiazole have been acylated by stirring with chloroacetyl chloride in benzene and pyridine at 20-30°C for 1 h. Compounds thus obtained have been reacted with ammonium thiocyanate in ethanol to yield thiazolidin-4-one ring which have been then refluxed in order to accomplish the condensation reaction with isatin or isatin derivatives and sodium acetate in acetic acid anhydride and glacial acetic acid at 150-160°C. Purity of the novel compounds were controlled by thin-layer chromatography and their structures were determined by elemental analyses, UV, IR, 1H-NMR, 13C-NMR and El Mass spectrometric data. In the 1H-NMR spectra, some of the protons appeared as double singlets or double doublets which led us to the conclusion that the partial restrictions of the rotations around the imino and ylidene bonds resulted in the presence of geometrical isomers (E and Z isomers) that are constantly converting to each other. On the other hand, the N-H proton of the thiazolidinone lactam group showed peaks at 1 1.73-14.04 ppm as expected proving that the structure of the compounds were 2-aminothiazolidin-4-one rather than 2-iminothiazolin-4-one. 227

Özet (Çeviri)

13C-NMR spectrum of Compound XVIII which was chosen as a prototype confirmed the structure. In the literature survey it was found that analogs of our compounds showed antimicrobial and anticonvulsant activities. All our compounds were tested for antibacterial activity at the Microbiology Department of our faculty, for antifungal activity at the Microbiology Department of Istanbul Medicine Faculty and for antituberculosis activity at Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) Southern Research Institute and their anticonvulsant activity was evaluated at the Pharmacology Department of our faculty. All compounds showed antifungal activity while Compounds l-XII showed antibacterial activity against S.epidermidis ATCC 12228 and Compounds IV, VI, X-XII against S.aureus ATCC 6538. All of the compounds were tested against M.tuberculosis H37Rv but the highest inhibition at 6.25 \xg/m\ was found to be 12%. Investigation of anticonvulsant activity which was carried on Compounds I, IV, V, VI, VIII, XI, XIII, XVI, XVII, XVIII that were chosen as prototypes revealed that all of the chosen compounds other than Compounds I and VI and have considerably increased the seizure latency statistically and that the same compounds have raised the seizure threshold induced by PTZ. As a result, they are expected prospectively to be compounds with anticonvulsant activity and it is worth carrying on further anticonvulsant activity testing higher doses. 228

Benzer Tezler

  1. İndol halkası taşıyan benziliden hidrazid ve 4-tiyazolidinon türevi bileşikler üzerine araştırmalar

    Studies on benzylidene hydrazide and 4-thiazolidinone derivatives carrying an ındole nucleus

    GÖKÇE CİHAN

    Doktora

    Türkçe

    Türkçe

    2010

    Eczacılık ve Farmakolojiİstanbul Üniversitesi

    Farmasötik Kimya Ana Bilim Dalı

    PROF. DR. GÜLTAZE ÇAPAN

  2. 3-sülfamoilfenil artığı taşıyan 1H-iNDOL-2,3-DİON 3-tiyosemikarbazon türevleri: Sentez, yapı tayini, moleküler modelleme ve biyolojik aktivite tayini

    1h-indole-2,3-DİONE 3-thiosemicarbazone derivatives carrying 3-sulfamoylphenyl moiety: Synthesis, structure determination, molecular modeling and biological activity evaluation

    PINAR ERASLAN ELMA

    Doktora

    Türkçe

    Türkçe

    2017

    Eczacılık ve Farmakolojiİstanbul Üniversitesi

    Farmasötik Kimya Ana Bilim Dalı

    PROF. DR. NİLGÜN LÜTFİYE KARALI

  3. İndol türevi spirotiyazolidinonların sentezi ve yapılarının aydınlatılması

    Synthesis and structure determination of spirothiazolidinones with an indole core

    MUHAMMET ZOPUN

    Yüksek Lisans

    Türkçe

    Türkçe

    2013

    Kimyaİstanbul Üniversitesi

    Farmasötik Kimya Ana Bilim Dalı

    PROF. DR. GÜLTAZE ÇAPAN

  4. 3-fenil-5-sülfamoil-1H-indol artığı taşıyan spirotiyazolidinon türevlerinin sentezi, yapı tayini ve biyolojik etkilerinin incelenmesi

    The synthesis, structure elucidation and biological testing of 3-phenyl-5-sulfamoyl-1H-indole moiety bearing spirothiazolidinone derivatives

    MEHTAP BABUÇ

    Yüksek Lisans

    Türkçe

    Türkçe

    2015

    Kimyaİstanbul Üniversitesi

    Farmasötik Kimya Ana Bilim Dalı

    DOÇ. DR. ÖZLEN GÜZEL AKDEMİR

  5. Bazı 2-((4-karbetoksimetiltiyazol-2-il)imino)- 4-tiyazolidinon türevlerinin sentezi ve yapılarının aydınlatılması

    Synthesis, structure elucidation and antimicrobial activity of some 2-((4-carbethoxymethylthiazol-2-yl)imino)- 4- thiazolidinone derivatives

    HANDAN ALTINTAŞ

    Yüksek Lisans

    Türkçe

    Türkçe

    1998

    Eczacılık ve Farmakolojiİstanbul Üniversitesi

    Farmasötik Kimya Ana Bilim Dalı

    PROF. DR. ÖZNUR ATEŞ